Thomasville National Bank purchased a new position in Lam Research Corporation (NASDAQ:LRCX - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 8,000 shares of the semiconductor company's stock, valued at approximately $3,467,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Cedar Mountain Advisors LLC increased its holdings in shares of Lam Research by 242.9% in the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company's stock valued at $26,000 after purchasing an additional 85 shares during the period. Vermillion Wealth Management Inc. purchased a new stake in Lam Research in the first quarter valued at approximately $26,000. Hughes Financial Services LLC increased its holdings in Lam Research by 54.9% in the 2nd quarter. Hughes Financial Services LLC now owns 141 shares of the semiconductor company's stock worth $61,000 after buying an additional 50 shares during the period. Bayban acquired a new position in Lam Research in the 4th quarter worth approximately $26,000. Finally, Mcguire Capital Advisors Inc. purchased a new position in Lam Research during the 4th quarter worth approximately $27,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In other news, Director Eric Brandt sold 54,500 shares of the stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the transaction, the director owned 199,205 shares in the company, valued at $69,881,114. This trade represents a 21.48% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of Lam Research stock in a transaction on Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the sale, the director directly owned 87,142 shares in the company, valued at $29,192,570. This represents a 17.34% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 80,441 shares of company stock worth $27,614,296 in the last quarter. Corporate insiders own 0.31% of the company's stock.
Lam Research Stock Performance
NASDAQ LRCX opened at $327.92 on Wednesday. The stock has a market capitalization of $410.33 billion, a price-to-earnings ratio of 56.93, a PEG ratio of 1.32 and a beta of 1.84. Lam Research Corporation has a twelve month low of $94.11 and a twelve month high of $438.50. The company has a current ratio of 2.63, a quick ratio of 1.91 and a debt-to-equity ratio of 0.30. The stock has a 50-day moving average of $339.86 and a 200 day moving average of $284.93.
Lam Research (NASDAQ:LRCX - Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The company had revenue of $6.72 billion for the quarter, compared to the consensus estimate of $6.66 billion. During the same quarter in the prior year, the business posted $1.33 earnings per share. Lam Research's revenue for the quarter was up 30.0% on a year-over-year basis. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Sell-side analysts anticipate that Lam Research Corporation will post 9.32 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several analysts have recently commented on the stock. JPMorgan Chase & Co. upped their price objective on shares of Lam Research from $300.00 to $315.00 and gave the company an "overweight" rating in a report on Thursday, April 23rd. Weiss Ratings cut shares of Lam Research from a "buy (b)" rating to a "buy (b-)" rating in a report on Friday, August 7th. TD Cowen restated a "buy" rating and set a $400.00 target price (up from $340.00) on shares of Lam Research in a research report on Thursday, July 9th. Barclays reaffirmed an "overweight" rating and issued a $335.00 price target (up from $275.00) on shares of Lam Research in a report on Thursday, June 11th. Finally, Raymond James Financial set a $425.00 price target on Lam Research in a research report on Wednesday, June 10th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, Lam Research presently has an average rating of "Moderate Buy" and a consensus price target of $358.47.
Check Out Our Latest Analysis on Lam Research
Lam Research Profile
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Further Reading
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
